Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin.

Haynes JR, Arrington J, Dong L, Braun RP, Payne LG.

Vaccine. 2006 Jun 5;24(23):5016-26. Epub 2006 Mar 31.

PMID:
16621198
5.

IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

Sin JI, Kim JJ, Arnold RL, Shroff KE, McCallus D, Pachuk C, McElhiney SP, Wolf MW, Pompa-de Bruin SJ, Higgins TJ, Ciccarelli RB, Weiner DB.

J Immunol. 1999 Mar 1;162(5):2912-21.

6.
9.

LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.

Sin JI, Kim J, Dang K, Lee D, Pachuk C, Satishchandran C, Weiner DB.

Cell Immunol. 2000 Jul 10;203(1):19-28. Erratum in: Cell Immunol 2000 Sep 15;204(2):150. Patchuk, C [corrected to Pachuk, C].

PMID:
10915558
11.

Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects.

Facciabene A, Aurisicchio L, Elia L, Palombo F, Mennuni C, Ciliberto G, La Monica N.

Vaccine. 2007 Dec 21;26(1):47-58. Epub 2007 Nov 20.

PMID:
18055074
12.

Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.

Melkebeek V, Verdonck F, Goddeeris BM, Cox E.

Vet Immunol Immunopathol. 2007 Apr 15;116(3-4):199-214. Epub 2007 Feb 4.

PMID:
17331591
13.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
14.
15.
16.
17.

The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27.

Bright H, Perez DL, Christy C, Cockle P, Eyles JE, Hammond D, Khodai T, Lang S, West K, Loudon PT.

Vaccine. 2012 Dec 14;30(52):7529-35. doi: 10.1016/j.vaccine.2012.10.046. Epub 2012 Oct 25.

PMID:
23103198
18.
20.

A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.

Goel N, Rong Q, Zimmerman D, Rosenthal KS.

Vaccine. 2003 Oct 1;21(27-30):4410-20.

PMID:
14505924

Supplemental Content

Support Center